[PAR] QoQ Quarter Result on 31-Dec-2019 [#Q2]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
30-Dec-2019
Financial Year
2020
Quarter
31-Dec-2019 [#Q2]
Profit Trend
QoQ- 54.54%
YoY- -16.00%
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/12/20 30/06/20 31/12/19 30/06/19 31/12/18 30/06/18 CAGR
Revenue 21 0 -826 826 2,956 28 2,660 -80.05%
PBT -13,567 -20,730 -7,195 -5,104 -11,227 -4,400 -2,617 72.98%
Tax 0 -0 -826 826 2,956 0 0 -
NP -13,567 -20,730 -7,195 -5,104 -11,227 -4,400 -2,617 72.98%
Tax Rate - - - - - - - -
Total Cost 13,587 20,730 6,369 5,930 14,183 4,428 5,277 37.02%
Ratio Analysis
30/06/21 31/12/20 30/06/20 31/12/19 30/06/19 31/12/18 30/06/18 CAGR
NP Margin -66,017.95 0.00 871.10 -617.95 -379.84 -15,637.06 -98.38 773.75%
Per Share
30/06/21 31/12/20 30/06/20 31/12/19 30/06/19 31/12/18 30/06/18 CAGR
EPS -0.06 -0.09 -0.03 -0.03 -0.08 -0.03 -0.02 44.17%
EPS Diluted -0.06 -0.09 -0.03 -0.03 -0.08 -0.03 -0.02 44.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.